Please provide your email address to receive an email when new articles are posted on . Laser treatments, anti-VEGF injections and surgery can all be used to treat diabetic retinopathy. David Baxley, ...

In patients with proliferative diabetic retinopathy, treatment with anti–vascular endothelial growth factor (anti-VEGF) may offer a safer alternative to panretinal photocoagulation (PRP), leading to ...

Non-proliferative diabetic retinopathy is the earliest stage of this diabetes complication. You may not have symptoms, and medical treatments may not be needed aside from diabetes management. As ...

Use of the cholesterol-lowering drug fenofibrate had a modest but statistically significant association with reduced risk of vision-threatening diabetic retinopathy (VTDR), according to results of a ...

Survival models using EHR data predicted progression from NPDR or DME to PDR in type 2 diabetes patients. Key risk factors for progression included age, race, NPDR severity, and diabetic nephropathy.

Add Yahoo as a preferred source to see more of our stories on Google. Thanks to advancements in early detection and treatment options, it’s possible to live a long and healthy life after being ...

Please provide your email address to receive an email when new articles are posted on . Regillo discussed treatment with panretinal photocoagulation vs. anti-VEGF therapy, as well as when to use both.

A new retinopathy position statement from the American Diabetes Association (ADA) reflects the "dramatic" improvements in both assessment and treatment in the 15 years since ADA's last guidance on ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. This piece also marks part ...

Share on Pinterest A study finds 1 in 4 people with diabetes have diabetic retinopathy. Azman Jaka/Getty Images A new study finds a quarter of people with diabetes have retinopathy. Diabetic ...